Events
-
-
-
-
HTAi 2023 Asia Policy Forum
HTAi Review | December 8, 2025The HTAi 2023 Asia Policy Forum will take place November 1 -3, 2023, in Taipei, Taiwan. The theme of the meeting is “Being Bold: How HTA Can Foster Innovation in […]
-
-
-
Webinar: Regulatory updates on harmonization of HTA among medical devices and digital medicine
This webinar is hosted by the HTAi Medical Devices Interest Group (MDIG) Overview On regulatory basis, the safety, performance, risks and benefits of medical devices are strongly regulated before market […]
-
HTAi Offices Closed
The HTAi Secretariat will be closed for a holiday break, returning to the office January 2, 2024.
-
-
Webinar: Ethical analyses at HTA agencies: challenges and opportunities
Hosted by the HTAi Ethics Interest Group, this webinar will discuss the challenges and opportunities for being involved in conducting ethical analyses at HTA agencies. Bart Bloemen, co-chair of the […]
-
-
2024 Global Policy Forum
HTAi Policy Forums provide the opportunity to interact and network with various stakeholders on a one-on-one basis, have open group discussions around relevant and pertinent topics, and have direct impact […]
-
-
Nomination Deadline For the 2024 Board of Directors Election
Joining the HTAi Board of Directors is the perfect opportunity to support HTAi’s future and make an impact in the global HTA community. The HTAi Board of Directors and its Nominating Committee […]
-
Jordi Llinares Garcia Memorial Award Submission Deadline
The HTAi RWE&AI Interest Group is pleased to announce an exceptional opportunity available to students presenting at the HTAi 2024 Annual Meeting. Students with accepted abstracts linked to real-world evidence […]
-
EOI Submission Deadline for DCIG Vice Chair, Steering Committee
DCIG is currently accepting expressions of interest from those wishing to join the Steering Committee, in particular, the IG has open positions for : Vice Chair Steering Committee members All candidates […]
-
The Characteristics of Rare Diseases That Complicate the Assessment of Technology Value
Evaluating the value of rare disease technologies poses challenges due to factors like poor natural history, small populations, limited data, complexity, and high unmet needs. Challenges vary across the spectrum […]
